GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: LY-2062430
Compound class:
Antibody
Comment: Solanezumab is an investigational humanized monoclonal antibody targeting amyloid-β (Aβ).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. The invention of solanezumab is covered by patent US7195761 [2], where it is coded as Hu266. |
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9097 | solanezumab |
Synonyms ![]() |
| LY-2062430 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 298 |
| Other databases | |
| GtoPdb PubChem SID | 178103514 |
| PubChem SID | 178103514 |
| Search PubMed clinical trials | solanezumab |
| Search PubMed titles | solanezumab |
| Search PubMed titles/abstracts | solanezumab |
| Wikipedia | Solanezumab |